920979-04-0

Basic information

• Product Name: 3-Amino-2-iodo-6-(trifluoromethyl)-pyridine
• Synonyms: 3-Amino-2-iodo-6-(trifluoromethyl)-pyridine;3-Amino-6-iodo-2-trifluoromethylpyridine;5-Amino-6-iodo-2-(trifluoromethyl)pyridine
• CAS NO: 920979-04-0
• Molecular Formula: C₆H₄F₃IN₂
• Molecular Weight: 288.01
• Mol File: 920979-04-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 233.1°C at 760 mmHg
• Flash Point: 94.8°C
• Appearance: /
• Density: 1.892g/cm³
• Vapor Pressure: 0.0867mmHg at 25°C
• Refractive Index: 1.586
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 3-Amino-2-iodo-6-(trifluoromethyl)-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-2-iodo-6-(trifluoromethyl)-pyridine(920979-04-0)
• EPA Substance Registry System: 3-Amino-2-iodo-6-(trifluoromethyl)-pyridine(920979-04-0)

Safety Data

• Hazardous Substances Data: 920979-04-0(Hazardous Substances Data)

Usage

General Description

3-Amino-2-iodo-6-(trifluoromethyl)pyridine is a chemical compound with a molecular formula C6H4F3IN2. It is a derivative of pyridine, and it contains an amino group, an iodine atom, and a trifluoromethyl group. 3-Amino-2-iodo-6-(trifluoromethyl)-pyridine is often used in organic synthesis and pharmaceutical research due to its versatile reactivity and unique structural properties. It can be employed as a building block in the synthesis of various heterocyclic compounds and functional materials. Additionally, its trifluoromethyl group makes it a potentially valuable moiety for drug design and discovery, as fluorine substitutions are known to enhance the physicochemical properties and pharmacological activities of bioactive molecules. However, it is important to handle this chemical with caution, as it may be hazardous if not properly handled and used in a controlled manner.

InChI:InChI=1/C6H5FIN/c1-4-2-3-5(8)6(7)9-4/h2-3H,1H3

Upstream product

• 106877-33-2 6-(trifluoromethyl)pyridin-3-amine 

Downstream Products

• 920979-05-1 (5-trifluoromethyl)pyrrolo[3,2-b]pyridine-2-carboxylic acid 
• 1068971-33-4 2-(3-fluoro-phenyl)-4-methyl-pyrimidine-5-carboxylic acid (3-ethyl-5-trifluoromethyl-pyrrolo[3,2-b]pyridin-1-yl)-amide 
• 1314186-71-4 3-(1,1-dimethylethyl)-N-(2-iodo-6-trifluoromethylpyridin-3-yl)benzenesulfonamide 
• 1314841-36-5 2-bromomethyl-1-(3-(1,1-dimethylethyl)phenylsulfonyl)-5-trifluoro-methyl-1H-pyrrolo[3,2-b]pyridine 
• 1314841-35-4 [1-(3-(1,1-dimethylethyl)phenylsulfonyl)-5-trifluoromethyl-1H-pyrrolo[3,2-b]pyridin-2-yl]methanol 
• 1314841-37-6 5-[[1-[[3-(1,1-dimethylethyl)phenyl]sulfonyl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridin-2-yl]methyl]-thiophene-2-carboxylic acid 
• 1314841-92-3 2-bromomethyl-1-(3-(1,1-dimethylethyl)phenylsulfonyl)-3-methyl-5-trifluoromethyl-1H-pyrrolo[3,2-b]pyridine 
• 1314841-91-2 4-[[1-[[3-(1,1-dimethylethyl)phenyl]sulfonyl]-3-methyl-5-(trifluoro-methyl)-1H-pyrrolo[3,2-b]pyridin-2-yl]methyl]benzoic acid 
• 1314841-90-1 1-(3-(1,1-dimethylethyl)phenylsulfonyl)-2,3-dimethyl-5-trifluoro-methyl-1H-pyrrolo[3,2-b]pyridine 
• 1314841-50-3 2-[1-(3-(1,1-dimethylethyl)phenylsulfonyl)-5-trifluoromethyl-1H-pyrrolo[3,2-b]pyridin-2-yl]thioacetamide 
• 1314841-49-0 [1-(3-(1,1-dimethylethyl)phenylsulfonyl)-5-trifluoromethyl-1H-pyrrolo[3,2-b]pyridin-2-yl]acetonitrile 

Relevant articles and documents

ISOINDOLINES AS HDAC INHIBITORS

The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs), having the formula: (I) wherein Z, X1, X2, Y1, Y2, Y3, L, Z, and R are described herein.

N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy

The invention relates to compounds of the general formula (I): Wherein X, Y, Z, Z1, Z2, Z3, Z4 and n are as defined herein. The invention also relates to a method for making the same and to the use thereof in th

TRICYCLIC N-HETEROARYL-CARBOXAMIDE DERIVATIVES CONTAINING A BENZIMIDAZOLE UNIT, METHOD FOR PREPARING SAME AND THEIR THERAPEUTIC USE

The invention concerns tricyclic N-heteroarylcarboxamide derivatives containing a benzimidazole unit of general formula (I): Wherein A, P, Y, R1, R2 and R3 are as defined herein. The invention also concerns a method of preparing the compounds and their therapeutic use.